Published in N Engl J Med on April 03, 1969
Allo-Antibodies in Pediatric Heart Transplantation | NCT01005316
Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol (2010) 2.66
The antibody crossmatch in liver transplantation. Surgery (1986) 2.33
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant (2015) 2.04
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation (2009) 1.76
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One (2008) 1.67
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood (2011) 1.61
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: a decision model analysis. Am J Transplant (2015) 1.41
Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant (2010) 1.39
Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33
The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol (2012) 1.29
Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol (2012) 1.21
Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients. Arch Dis Child (1972) 1.20
Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. Clin Exp Immunol (2009) 1.16
The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13
Antibody-mediated rejection in kidney transplantation: a review. J Transplant (2012) 1.12
Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study. Am J Pathol (1972) 1.05
Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. J Clin Invest (1972) 1.05
Red blood cell age and potentiation of transfusion-related pathology in trauma patients. Transfusion (2011) 1.05
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol (2009) 1.04
Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol (2008) 1.04
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) (2009) 1.03
New concepts of complement in allorecognition and graft rejection. Cell Immunol (2007) 1.02
Kidney paired donation in the presence of donor-specific antibodies. Kidney Int (2013) 1.01
Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. Transplant Proc (1988) 0.99
Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera. Proc Natl Acad Sci U S A (1973) 0.98
Clinical patterns of renal allograft rejection. Ann Surg (1971) 0.98
Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation (1989) 0.98
The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96
Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection. Xenotransplantation (2011) 0.95
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg (1996) 0.95
Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol (2010) 0.94
Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol (2015) 0.93
Antibodies and human transplant rejection. Ann Surg (1969) 0.92
Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion. Transfus Med Hemother (2013) 0.92
Comparative studies on fresh and preserved skin: fundamental biologic differences in behavior as grafts. Ann Surg (1970) 0.91
Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation (2010) 0.91
Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes. Ann Surg (1987) 0.91
Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol (2015) 0.91
History of clinical transplantation. World J Surg (2000) 0.91
A prospective study of histocompatibility testing for keratoplasty in high-risk patients. Br J Ophthalmol (1986) 0.90
Complement as a multifaceted modulator of kidney transplant injury. J Clin Invest (2014) 0.89
Approach to the Highly Sensitized Kidney Transplant Candidate. Clin J Am Soc Nephrol (2016) 0.89
Mechanisms involved in antibody- and complement-mediated allograft rejection. Immunol Res (2010) 0.88
A 14-year experience with kidney transplantation. World J Surg (1977) 0.88
An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival. BMC Nephrol (2013) 0.87
Antibody-mediated rejection: emergence of animal models to answer clinical questions. Am J Transplant (2010) 0.87
HLA antibody testing: a tool to facilitate not to prevent organ transplantation. Int J Immunogenet (2008) 0.86
Human leukocyte antigen antibodies for monitoring transplant patients. Surg Today (2005) 0.86
Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation. Am J Pathol (1975) 0.86
Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc (1988) 0.86
Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching. NDT Plus (2010) 0.86
HLA Genotyping and Antibody Characterization Using the Luminex™ Multiplex Technology. Transfus Med Hemother (2009) 0.85
Artificially Positive Crossmatches Not Leading to the Refusal of Kidney Donations due to the Usage of Adequate Diagnostic Tools. Case Rep Transplant (2013) 0.85
Predicting alloreactivity in transplantation. J Immunol Res (2014) 0.84
Tissue matching and early rejection of cadaveric-donor renal allografts: the importance of unidentified donor antigens. Br Med J (1970) 0.84
Moving beyond HLA: a review of nHLA antibodies in organ transplantation. Hum Immunol (2013) 0.83
Recent advances in renal transplantation: antibody-mediated rejection takes center stage. F1000Prime Rep (2015) 0.83
Human leukocyte antigen antibody incompatible renal transplantation. Indian J Nephrol (2012) 0.83
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood (2007) 0.83
A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates. Transplant Direct (2015) 0.82
Goodpasture's syndrome. Treatment with nephrectomy and renal transplantation. Arch Surg (1971) 0.82
Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol (2013) 0.82
Luminex and antibody detection in kidney transplantation. Clin Exp Nephrol (2012) 0.82
Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury. J Clin Invest (1981) 0.82
Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. Trans Am Clin Climatol Assoc (2006) 0.81
Red blood cell transfusion risks in patients with end-stage renal disease. Semin Dial (2012) 0.81
Challenges with sensitized recipients in pediatric heart transplantation. Clinics (Sao Paulo) (2014) 0.81
Transplant immuno-diagnostics: crossmatch and antigen detection. Pediatr Nephrol (2015) 0.80
Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol (2001) 0.80
The role of humoral antibody in the rejection of primary renal allografts in sheep. J Exp Med (1974) 0.80
Mixed lymphocyte culture in histocompatiibility testing for familial renal transplantation. Ann Surg (1972) 0.79
Kidney transplantation in sensitized recipients; a single center experience. J Korean Med Sci (2009) 0.79
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol (2016) 0.79
Effects of complement activation on allograft injury. Curr Opin Organ Transplant (2015) 0.79
The Denver-Pittsburgh liver transplant series. Clin Transpl (1987) 0.79
Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients. Clin Exp Immunol (1973) 0.79
Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol (2016) 0.78
Solid phase-based cross-matching as solution for kidney allograft recipients pretreated with therapeutic antibodies. Biomed Res Int (2015) 0.78
Positive, warm T cell crossmatch in cardiac transplantation: with transient vasculitis and without hyperacute rejection. Transplantation (1982) 0.78
The role of antibodies in transplantation. Transplant Rev (Orlando) (2009) 0.78
Lack of cross-sensitization between α-1,3-galactosyltransferase knockout porcine and allogeneic skin grafts permits serial grafting. Transplantation (2014) 0.78
Functional aspects of the rejection of transplanted kidneys. Calif Med (1971) 0.78
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol (2016) 0.78
B-cell complement dependent cytotoxic crossmatch positivity is an independent risk factor for long-term renal allograft survival. J Korean Med Sci (2011) 0.78
Pediatric renal transplantation in a highly sensitised child-8 years on. Case Rep Transplant (2012) 0.78
Relative importance of cellular and humoral immunity in human renal transplantation. Ann Surg (1971) 0.78
De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction? J Transplant (2012) 0.78
Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation. World J Transplant (2014) 0.78
Crossmatch testing in kidney transplantation: patterns of practice and associations with rejection and graft survival. Saudi J Kidney Dis Transpl (2009) 0.77
Antibody-incompatible kidney transplantation in 2015 and beyond. Nephrol Dial Transplant (2014) 0.77
Immunologic monitoring in kidney transplant recipients. Kidney Res Clin Pract (2013) 0.77
Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies. Clin Transplant (2013) 0.77
Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I. J Am Soc Nephrol (2014) 0.77
[Pregnancy-induced leukocyte-(HL-A) antibodies]. Arch Gynakol (1973) 0.77
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation (2015) 0.77
Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study. Transplant Direct (2016) 0.76
Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol (2015) 0.76
Updates on antibody-mediated rejection in intestinal transplantation. World J Transplant (2016) 0.76
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Access to genitourinary medicine clinics in the United Kingdom. Sex Transm Infect (2001) 3.79
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Epoxidation of short-chain alkenes by resting-cell suspensions of propane-grown bacteria. Appl Environ Microbiol (1983) 3.30
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect (2004) 3.25
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother (2006) 3.25
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Should men with asymptomatic non-specific urethritis be identified and treated? Int J STD AIDS (2008) 2.66
The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther (2007) 2.59
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess (2007) 2.23
Delayed side effects of droperidol after ambulatory general anesthesia. Anesth Analg (1989) 2.23
The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease. Am J Gastroenterol (2001) 2.21
Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods. J Clin Microbiol (2001) 2.16
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol (2001) 2.11
Isolation and restriction endonuclease analysis of mycobacterial DNA. J Gen Microbiol (1986) 2.11
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) tube placement: a novel approach. Gastrointest Endosc (1997) 2.05
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
The use of alternative therapies by Auckland general practitioners. N Z Med J (1990) 1.89
Microbial oxidation of gaseous hydrocarbons: epoxidation of C2 to C4 n-alkenes by methylotrophic bacteria. Appl Environ Microbiol (1979) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Undergraduate teaching of genitourinary medicine in Britain--what are the issues? Genitourin Med (1996) 1.88
Calcium and cell cycle control. Development (1990) 1.87
A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
Self-assembly of collagen fibers. Influence of fibrillar alignment and decorin on mechanical properties. Biophys J (1997) 1.77
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70
Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol (2001) 1.68
Microbial oxidation of gaseous hydrocarbons: production of methyl ketones from their corresponding secondary alcohols by methane- and methanol-grown microbes. Appl Environ Microbiol (1979) 1.67
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Imaging of the complications of peripherally inserted central venous catheters. Clin Radiol (2009) 1.67
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Fractures of the acetabulum in patients aged 60 years and older: an epidemiological and radiological study. J Bone Joint Surg Br (2010) 1.63
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Tinted spectacles and visually sensitive migraine. Cephalalgia (2002) 1.62
Early maternal and neonatal morbidity associated with operative delivery in second stage of labour: a cohort study. Lancet (2001) 1.61
In-hospital mortality rates from acute myocardial infarction by race in U.S. hospitals: findings from the National Hospital Discharge Survey. Circulation (1987) 1.60
Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
A quantitative immunohistochemical study of macroglial cell development in the rat optic nerve: in vivo evidence for two distinct astrocyte lineages. Dev Biol (1985) 1.59
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc Natl Acad Sci U S A (2001) 1.56
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55
2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol (2014) 1.54
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem (1998) 1.51
Translational control of InsP3-induced chromatin condensation during the early cell cycles of sea urchin embryos. Nature (1988) 1.50
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46
Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
HSV-1 genital infection rare in men over the age of 35 years. Int J STD AIDS (2009) 1.44
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41
Inhibition of dimethyl ether and methane oxidation in Methylococcus capsulatus and Methylosinus trichosporium. J Bacteriol (1976) 1.41
Chlamydia trachomatis detection and non-invasive sampling methods. Lancet (1991) 1.40
HLA matching assessed from early graft function. Transplant Proc (1987) 1.40
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40
Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal Biochem (1998) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40